Re-expression of the RASSF1A gene not only inhibits the growth of HCC cells in vitro and in vivo but also increases the sensitivity of HCC cells to the chemotherapy drug mitomycin (MMC)13. Here, RASSF1 is linked to hepatocellular carcinoma.